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Introduction
Giant condyloma acuminatum (GCA) is a tumour primarily
affecting the genital and perianal areas. It is also known as
Buschke-Lowenstein tumour following the original descrip-
tion by these authors in 1925 of a lesion of the penis,1 the most
common site for this tumour. Despite the histologically be-
nign appearance, it behaves clinically in a malignant fashion,
destroying adjacent tissues, and is regarded as an entity inter-
mediate between an ordinary condyloma acuminatum and
squamous cell carcinoma.2 Primary anorectal lesions account
for only a small number of GCA cases and, as with squamous
cell carcinoma, the human papilloma virus (HPV) has been
identified as the causative agent.3–6 The hallmark of this dis-
ease is the high rate of local recurrence and transformation
into squamous cell carcinoma.7 In this report, we describe a
case of GCA complicated by malignant transformation, where
locoregional control was achieved with combined chemo-
radiotherapy.
Squamous Cell Carcinoma Arising in a Giant Condyloma
Acuminatum (Buschke-Lowenstein Tumour)
Case report
A 57-year-old heterosexual white male with a long history
of severe psoriasis presented with a GCA with malignant
transformation. His medical history was unremarkable apart
from the psoriasis and he denied any risk factors for human
immunodeficiency virus (HIV) infection. He had first noted an
indurated lesion adjacent to his anus 1 year prior to diagnosis.
Apart from mild perianal discomfort, there were no other
symptoms. The treating physician made the clinical diagnosis
of psoriasis and local therapy was delivered with topical ster-
oids and, subsequently, imiquimod (AldaraTM, 3M, Pymble,
New South Wales, Australia). The lesion continued to grow, so
a biopsy was performed. This revealed a giant anal condyloma
containing well-differentiated squamous cell carcinoma with
superficial invasion.
On examination, a large perianal tumour (8 = 6 cm in dia-
meter) extended from the distal anal canal to the adjacent
left buttock (Figure 1). No inguinal lymphadenopathy was
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fistula and ulcerative colitis has been implicated in anal
occurrence of this tumour.9,11 The mean age of patients
with perianal GCA is 43 years, with a male to female ratio of
2.2 to 1.9,11,12 The risk of recurrence after excision is 60–66%,
with an overall mortality of 20–30%.9,11,12 Malignant trans-
formation has been reported in 30–56% of cases.9,11,12
The standard approach to perianal GCA is radical surgical
excision. Patients with extensive lesions, especially those with
multiple fistulous tracts and purulent discharge, may require
a temporary loop colostomy. Any compromise regarding
radicality is reported to predispose to local recurrence.9,13–15
For this reason, some have advocated abdominoperineal re-
section (APR) in cases with infiltration of sphincter muscles
or the rectum.14,16,17
In patients with GCA with malignant transformation, the
optimal treatment is not well defined. In a review of 11 patients
treated with radical surgery, only five remained disease
free.12 This has prompted some to recommend preoperative
chemoradiotherapy to downstage extensive tumours, followed
by radical surgery.13 For classical anal canal cancers, the role of
chemotherapy and radiotherapy is now well established and
detected clinically or by computed tomography of the pelvis
and inguinal region. No distant metastases were detected.
Biochemical and serological investigations including HIV were
normal.
The patient received primary combined chemoradio-
therapy. Radiotherapy included 50.4 Gy to the primary tu-
mour and prophylactic irradiation of the perirectal (45 Gy)
and inguinal (36 Gy) lymph nodes. Chemotherapy consisted
of mitomycin C at 10 mg/m2 on day 1 and 5-fluorouracil
(5-FU) at 1 g/m2/day delivered as a continuous infusion for
4 days in the first and fifth weeks of radiotherapy.
The patient had a clinical complete response to primary
combined chemoradiotherapy, and had no evidence of recur-
rence at 12 months of follow-up (Figure 2). The patient denied
any abnormal anal or bowel function.
Discussion
GCA is caused by HPV types 6, 11 and 16.3–6 Risk factors in-
clude immunosuppression, chronic irritation and poor per-
sonal hygiene.8–10 Chronic irritation secondary to perianal
Figure 1. A 57-year-old heterosexual male with squamous cell
carcinoma arising in a giant condyloma acuminatum.
Figure 2. No evidence of locoregional recurrence 12 months after
combined chemoradiotherapy.
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the combined modality approach is superior to APR in terms
of colostomy-free survival, with many patients maintaining
good anal function.18
Several case reports have described patients with squa-
mous cell cancers arising from GCA responding well to radio-
therapy alone or chemoradiotherapy. Butler et al reported a
patient with unresectable disease who received combined
modality therapy.19 A pathological complete response was
demonstrated following APR 32 weeks later. Chu et al treated
a patient who had unresectable disease using preoperative
chemoradiotherapy followed by APR and reconstructive
surgery.11 This patient remained disease free at 22 months.
Marsh et al reported a patient with extensive locoregional
disease who was successfully palliated with chemoradio-
therapy.20 Finally, Bertram et al described two patients with
inoperable disease who proceeded to surgery following
successful downstaging with moderate-dose radiotherapy.12
This case demonstrates the successful treatment of an
invasive squamous cell carcinoma in the setting of GCA. A
clinical complete response was demonstrated following
chemoradiotherapy for a moderately large tumour. Further
follow-up is required to determine whether this will be durable.
This is consistent with the success achieved with large (T3–4)
classical anal canal tumours, where 50–70% of patients attain
a complete response. On the basis of this case and other
published reports, chemoradiotherapy should be considered
for patients with malignant transformation of GCA, with
surgical salvage in those who fail to respond or subsequently
progress.
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